Carnage among gold stocks as gold price rally

New Post Public Reply Private Reply Replies (0) Message Board
Lmcat

Carnage among gold stocks as gold price rally evaporates

The rally in the gold price reversed on Wednesday with the metal falling more than $20 to a day low of $1,313 after  better than expected economic news in the US and a stronger dollar dented confidence.

The gold price seemed to have turned a corner in July fighting back from near 3-year lows of $1,200 hit at the end of June, but it remains 21% cheaper than at the start of the year.

Gold stocks have suffered a worse fate than the metal and recent gains in the sector were looking in danger of evaporating on Wednesday.

In afternoon trade Barrick Gold Corp (TSX:ABX) lost 6.2% falling, well off 21-year lows struck in June, but still down 50% so far this year.

Barrick is now worth $17.6 billion on the TSX, nowhere near its market capitalization just two years ago of more than $54 billion.

The global number one gold company in terms of output has been dogged by problems this year with work at its massive Pascua-Lama project straddling the border between Chile and Argentina,  halted due to protests and legal challenges .

Denver-based Newmont Mining Corp (NYSE:NEM) with a market value of $15.7 billion, down from $30 billion last year, shed 5.8%.

The world's third largest gold producer behind Newmont, AngloGold Ashanti (NYSE:AU) also gave up more than 5.3%. AngloGold announced last week it will take as much as a $2.6 billion charge as it comes to grips with a lower gold price.

Th Johannesburg-based company's ADRs listed in New York are down 56% year to date as it struggles with  unrest in the its home country's mining sector and falling gold output.

Fellow South African miner Gold Fields (NYSE:GFI) fared better, with losses limited to 4.8%. The fourth largest gold producer has had its value slashed 54% in 2013.

Canadian gold counters Goldcorp (TSX:G) and Kinross Gold (TSX:K) – which this year overtook Goldcorp as the world fifth largest gold miner in terms of output – lost 5.8% and 6.3% respectively.

Goldcorp's market value peaked in 2011 at $30 billion and thanks to a relatively robust share price amid the general carnage – year to date losses are 'only' 20% – the Vancouver-based company is the most valuable gold stock.

Goldcorp's market value peaked in 2011 at $30 billion and thanks to a relatively robust share price amid the general carnage – year to date losses are 'only' 20% – the Vancouver-based company is the most valuable gold stock.

Australia's Newcrest Mining's (ASX:NCM) gained on the Sydney bourse and avoided much of the carnage in in New York as gold fell.

The company in June announced $6 billion in writedowns and a dividend cut, but suspicious price movements ahead of the news prompted an investigation by Australian market regulators and possible class action lawsuits on behalf of shareholders, who have seen their investment in the Melbourne-based company decline 45% this year.

Carnage among gold stocks as gold price rally evaporates Kinross, like all the majors, took multi-billion charges against the value of its operations with the Toronto firm writing down its ill-fated acquisition in Mauritania and abandoning a huge project in Ecuador. Kinross was one of the worst performers on the day is now worth 45% less than at the start of the year.

Ever volatile Harmony Gold Mining (NYSE:HMY) shed 6.5% in New York – the Johannesburg-based company is still almost 60% cheaper than at the start of the year giving the dubious distinction of being the worst performer in the sector year to date as it reassess operations in South African and Papua New Guinea.

Canada's Yamana Gold (TSX:YRI) lost 6.4%, while Agnico Eagle Mines (TSX:AEM) gave up 7.8% after two brokerages downgraded the stock.

Eldorado Gold Corp (TSX:ELD) declined 6.3%. Last week Eldorado announced 2013 capital expenditure cuts of 35%, as well as minimum yearlong delays at three key European gold mining projects.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 9

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

New S&P Lincoln Indices: A Bold Move in Private Loans

Updated Category News Views 231

The Shift in Private Loan Markets This takes me back to when the dot-com bubble burst—remember the chaos? Anyway, S&P Dow Jones Indices, that big player in the index game, is making waves again with the launch of the S&P Lincoln Senior Debt Indices. It’s a partnership with Lincoln International, and it’s all about filling a desperate gap in the private loan sector....

Continue Reading
Empowering Gender Equity: The Launch of State Policy Action Lab

Updated Category News Views 189

Empowering Gender Equity with a New Tool The Institute for Women's Policy Research (IWPR) has unveiled its latest innovative initiative, the State Policy Action Lab (State PAL). This interactive platform consolidates over 100 gender equity data indicators, tracks nearly 500 state-level legislative bills, and offers actionable policy recommendations all in one...

Continue Reading
P95's Expansion Journey: A Strategic Acquisition of Assign DMB

Updated Category News Views 77

P95's Strategic Acquisition: Enhancing Clinical Research Services P95 BV, a well-respected name in epidemiology and clinical solutions, has made a significant move by acquiring Assign DMB, a reputable clinical research organization. This acquisition is a crucial milestone for P95, which is known for its strong emphasis on vaccines and infectious diseases. It allows them...

Continue Reading
Empowering IT Departments Amid Global Challenges and Change

Updated Category News Views 151

Transforming IT in Times of Change As we navigate through an ever-evolving landscape marked by economic uncertainties and regulatory challenges, the role of IT leadership has become more vital than ever. The latest research from Info-Tech Research Group reveals that IT departments possess the potential to transform crises into opportunities, becoming agents of positive...

Continue Reading
Versa Networks Sets the Standard in Cybersecurity Ratings

Updated Category News Views 290

Versa Networks Achieves Top Ratings in CyberSecurity Solutions SANTA CLARA, Calif. -- Versa, recognized as a leader in Universal Secure Access Service Edge (SASE), has garnered significant achievements recently, with their Security Service Edge (SSE) and Zero Trust Network Access (ZTNA) both earning the prestigious “AAA” rating from CyberRatings.org, a reputable...

Continue Reading